In accordance with previous literature 18, human natural killer (NK) cells defined in this study as CD3–Vδ2–CD56+ lymphocytes could be separated broadly into CD56Dim and CD56Bright subsets in all Behçet's disease patients (BD) and healthy controls (HC) (Fig. 1a). The gene discussed is NCAM1; the disease is Behcet disease.